医学
诊断试验
诊断准确性
模式
梅德林
模态(人机交互)
医学物理学
医学影像学
放射科
医学诊断
考试(生物学)
计算机断层摄影术
诊断超声
治疗方式
电流(流体)
作者
Shyna Zhuoying Gunalan,Michelle Shi Ni Law,Yi Xin Kua,Zhenning Yu,Ryan Yanzhe Lim,Asvin Selvakumar,Nicholas L. X. Syn,Karn Wijarnpreecha,Benjamin Kai Yi Nah,Zi Xuan Zhang,Ming‐Hua Zheng,Toru Nakamura,Asahiro Morishita,Won‐Mook Choi,Vincent Lingzhi Chen,Cheng Han Ng,Mei Chin Lim,Hirokazu Takahashi,Mark Dhinesh Muthiah
标识
DOI:10.14309/ajg.0000000000003919
摘要
INTRODUCTION: Metabolic dysfunction-associated steatohepatitis (MASH) is an advanced form of metabolic dysfunction-associated steatotic liver disease, characterized by hepatocellular injury, inflammation, and varying degrees of fibrosis. Noninvasive, accurate diagnostic tools are critical for identifying patients at risk (metabolic activity score ≥4, F ≥ 2). This meta-analysis evaluates the diagnostic performance of imaging-based technologies for ruling-in (TRI) and ruling-out (TRO) at risk MASH. METHODS: A systematic search of Medline and Embase (inception to December 20, 2024) identified studies reporting on MRI-based diagnostic techniques for at risk MASH. Eligible studies were independently screened, with 20 studies meeting inclusion criteria. Sensitivity, specificity, and diagnostic odds ratios (DORs) were calculated using bivariate meta-analysis, applying prespecified TRO and TRI thresholds to each technique. RESULTS: Twenty studies involving 9,480 participants were included. FibroScan-aspartate aminotransferase (FAST) demonstrated highest TRO sensitivity (0.871) with moderate specificity (0.567) and TRI specificity (0.900) with reduced sensitivity (0.441). Magnetic resonance elastography plus fibrosis-4 achieved high TRO sensitivity (0.812) but lower specificity (0.606); TRI specificity was 0.872, sensitivity was 0.500. MRI-aspartate aminotransferase exhibited intermediate performance, while cT1 thresholds showed variable diagnostic accuracy. A sensitivity analysis of head-to-head studies shows superior performance in FAST compared with other diagnostic methods. DISCUSSION: FAST with its accessibility and robust diagnostic performance may be well-suited for large-scale application. MRI-based techniques are effective noninvasive options for diagnosing at risk MASH in metabolic dysfunction-associated steatotic liver disease and may provide strong alternatives. Rather than challenging existing perspectives, this study provides a reflective overview of current evidence on imaging-based modalities for at risk MASH.
科研通智能强力驱动
Strongly Powered by AbleSci AI